Jennifer E. Klomp

University of North Carolina at Chapel Hill — United States

Medicine · Health Sciences

19h-index2.2kcitations150works12.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(59), Advanced Breast Cancer Therapies(48), Colorectal Cancer Treatments and Studies(35), Hippo pathway signaling and YAP/TAZ(34), Protein Kinase Regulation and GTPase Signaling(10)

Publications150 total

Figure S3 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Figure S7 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Figure S2 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Figure S1 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Figure S4 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Figure S6 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Figure S5 page3 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Figure S5 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Figure S7 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Figure S2 page3 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Figure S2 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Figure S5 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Figure S5 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Supplementary Data and Materials from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Figure S1 page4 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Figure S1 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Figure S6 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Supplementary Tables from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Figure S1 page3 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
Figure S3 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
2025Open Access
page 1 of 8Next →

Frequent Co-authors

Channing J. Der(39), Adrienne D. Cox(37), Andrew M. Waters(34), Clint A. Stalnecker(33), Kirsten L. Bryant(22), Bjoern Papke(22), Mariaelena Pierobon(21), Craig M. Goodwin(20), Jeffrey A. Klomp(17), Kristina Drizyte‐Miller(15), Elisa Baldelli(15), A. Cole Edwards(15), Sehrish Javaid(14), Alexis Jean Morales(14), Khalilah E. Taylor(14), Emanuel F. Petricoin(13), Jill Hallin(13), Peter Olson(13), James G. Christensen(13), Runying Yang(12)